Summary slide.png (113.58 kB)
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection
figure
posted on 2020-04-09, 08:43 authored by Steven L. Flamm, Jens Kort, Steven E. Marx, John Strezewski, Douglas E. Dylla, Bruce Bacon, Michael P. Curry, Naoky Tsai, Nicole WickThe above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
